State Street SPDR Bloomberg 1-3 Month T-Bill ETF vs IDEXX Laboratories, Inc. — how do they compare? State Street SPDR Bloomberg 1-3 Month T-Bill ETF trades at $91.5, while IDEXX Laboratories, Inc. trades at $589.8 (market cap $46.22B). The key difference: State Street SPDR Bloomberg 1-3 Month T-Bill ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| BIL | IDXX | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $91.77 | $766.68 |
52-Week Low | $91.27 | $526.44 |
Market Cap | — | $46.22B |
Enterprise Value | — | $47.12B |
Trailing returns across standard periods
Latest headlines on both assets
BIL tracks the performance of short-term U.S. Treasury bills with maturities between 1 and 3 months. It is designed for investors seeking a highly liquid, low-risk vehicle for cash management and capital preservation.
Read more on BIL →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →